4-Hydroxynonenal-modified amyloid-β peptide inhibits the proteasome: possible importance in Alzheimer’s disease*
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
The amyloid beta-peptide (Abeta) is a 4-kDa species derived from the amyloid precursor protein, which accumulates in the brains of patients with Alzheimer's disease. Although we lack full understanding of the etiology and pathogenesis of selective neuron death, considerable data do imply roles for both the toxic Abeta and increased oxidative stress. Another significant observation is the accumulation of abnormal, ubiquitin-conjugated proteins in affected neurons, suggesting dysfunction of the proteasome proteolytic system in these cells. Recent reports have indicated that Abeta can bind and inhibit the proteasome, the major cytoslic protease for degrading damaged and ubiquitin-conjugated proteins. Earlier results from our laboratory showed that moderately oxidized proteins are preferentially recognized and degraded by the proteasome; however, severely oxidized proteins cannot be easily degraded and, instead, inhibit the proteasome. We hypothesized that oxidatively modified Abeta might have a stronger (or weaker) inhibitory effect on the proteasome than does native Abeta. We therefore also investigated the proteasome inhibitory action of Abeta1-40 (a peptide comprising the first 40 residues of Abeta) modified by the intracellular oxidant hydrogen peroxide, and by the lipid peroxidation product 4-hydroxynonenal (HNE). H2O2 modification of Abeta1-40 generates a progressively poorer inhibitor of the purified human 20S proteasome. In contrast, HNE modification of Abeta1-40 generates a progressively more selective and efficient inhibitor of the degradation of fluorogenic peptides and oxidized protein substrates by human 20S proteasome. This interaction may contribute to certain pathological manifestations of Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Effects of oxidative modification on the proteolytic susceptibility of hemoglobin. [ 3 H]-hemoglobin was exposed to various concentrations of hydrogen peroxide, microconcentrated, and then incubated for 1 h at 37 °C with purified human proteasome, to measure proteolytic susceptibility. All data are the means and SEs of three experiments.](https://figures.cochat.ai/paper-figures/fb1a617b5fd8485eb2889ac8c7402135/4-hydroxynonenal-modified-amyloid-peptide-inhibits-the-proteasome-possible-figure-2.png)
![Figure 3 Effects of A b 1-40 on the degradation of native and oxidized hemoglobin by the proteasome. A b 1-40 was oxidized as described in Materials and methods. Purified proteasome was incubated with various concentrations of oxidized A b 1-40 for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with H2O2 was added, and proteolysis was allowed to proceed for 1 h at 37 °C. Percent hemoglobin degradation was calculated as described in Materials and methods. Data are represented as means 9 SEs of triplicate samples from a total of four experiments. ( A ) Percent degradation of both native and oxidized (20 mM H2O2) [ 3 H]-hemoglobin by the purified human 20S proteasome, in the presence of native A b 1-40 . ( B ) Effect of oxidized A b 1-40 (30 mM H2O2) on the degradation of both native and oxidized (20 mM H2O2) hemoglobin by the proteasome.](https://figures.cochat.ai/paper-figures/1fdebe28f4e6449ea8bed334bd2748d9/4-hydroxynonenal-modified-amyloid-peptide-inhibits-the-proteasome-possible-figure-3.png)

![Figure 4 Oxidation of A b 1-40 inactivates its ability to inhibit the proteasome. Shown is the progressive oxidation of A b 1-40 as measured by carbonyl production with exposure to increasing concentrations of H2O2 ( A ) and that increasing oxidation progressively inactivates the ability of A b 1-40 to inhibit degradation of both native and oxidized hemoglobin by the proteasome ( B ). Carbonyl measurements, exposure of A b 1-40 and hemoglobin to H2O2, and calculation of percent hemoglobin degradation were performed as described in Materials and methods. Data are represented as means and SEs from four experiments. ( A , B ) The extent of A b oxidation was varied by pre-exposure to 0-30 mM hydrogen peroxide. ( B ) Purified human 20S proteasome was incubated with progressively oxidized A b for 1 h at room temperature. Next, native [ 3 H]-Hb or [ 3 H]-Hb oxidized with 20 mM H2O2 was added and proteolysis was allowed to proceed for 1 h at 37 °C.](https://figures.cochat.ai/paper-figures/e7b16cbaaa504574bcf9d609b4cbc07c/4-hydroxynonenal-modified-amyloid-peptide-inhibits-the-proteasome-possible-figure-4.png)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Proteasome dysfunction has been implicated in the pathogenesis of neurodegenerative diseases including Alzheimer’s disease [14], Parkinson’s disease [15], Huntington’s disease [16], and amyotrophic lateral sclerosis [17].”
From PSMC5 insufficiency and P320R mutation impair proteasome function (2024) · cites this paper as [14]
In the citing paper
“4-HNE-modified amyloid β peptides have been found to inhibit proteasomal function, leading to neuroinflammation which exacerbates neurodegeneration [51,53].”
From Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease? (2022) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[49] Determination of carbonyl content in oxidatively modified proteins
Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A.-G., Ahn, B.-W., Shaltiel, S., & Stadtman, E. R. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)86141-h · Cited by 5,887
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Protein Oxidation in Aging, Disease, and Oxidative Stress
Berlett, B. S., & Stadtman, E. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20313 · Cited by 3,332
STRUCTURE AND FUNCTIONS OF THE 20S AND 26S PROTEASOMES
Coux, O., Tanaka, K., & Goldberg, A. L. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.004101 · Cited by 2,487
Oxidative stress hypothesis in Alzheimer’s disease
Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383
The ubiquitin-proteasome proteolytic pathway
Ciechanover, A. (1994) · Cell · doi:10.1016/0092-8674(94)90396-4 · Cited by 1,791
Goldgaber, D., Lerman, M. I., McBride, O. W., Saffiotti, U., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3810169 · Cited by 1,333
The Genetic Defect Causing Familial Alzheimer's Disease Maps on Chromosome 21
St George-Hyslop, P. H., Tanzi, R. E., Polinsky, R. J., Haines, J. L., Nee, L., Watkins, P. C., Myers, R. H., Feldman, R. G., Pollen, D., Drachman, D., et al. (1987) · Science · doi:10.1126/science.2880399 · Cited by 1,163
Ubiquitin Is a Component of Paired Helical Filaments in Alzheimer's Disease
Mori, H., Kondo, J., & Ihara, Y. (1987) · Science · doi:10.1126/science.3029875 · Cited by 843
Radioactive Labeling of Proteins in Vitro
Rice, R. H., & Means, G. E. (1971) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62484-6 · Cited by 835
Cited by
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Antioxidant Activity of Proteins and Peptides
Elias, R. J., Kellerby, S. S., & Decker, E. A. (2008) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390701425615 · Cited by 1,349
Degradation of oxidized proteins by the 20S proteasome
Davies, K. J. A. (2001) · Biochimie · doi:10.1016/s0300-9084(01)01250-0 · Cited by 855
Self-citationProtein carbonylation, cellular dysfunction, and disease progression
Dalle-Donne, I., Aldini, G., Carini, M., Colombo, R., Rossi, R., & Milzani, A. (2006) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2006.tb00407.x · Cited by 831
Grune, T., Jung, T., Merker, K., & Davies, K. J. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.04.020 · Cited by 655
Self-citationNegre‐Salvayre, A., Coatrieux, C., Ingueneau, C., & Salvayre, R. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707395 · Cited by 641
Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance
Dalleau, S., Baradat, M., Guéraud, F., & Huc, L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.138 · Cited by 580
Proteasome inhibition by paired helical filament‐tau in brains of patients with Alzheimer's disease
Keck, S., Nitsch, R., Grune, T., & Ullrich, O. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01642.x · Cited by 483
Self-citationSelective degradation of oxidatively modified protein substrates by the proteasome
Grune, T., Merker, K., Sandig, G., & Davies, K. J. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00809-x · Cited by 475
Self-citationPathological aspects of lipid peroxidation
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 449
Self-citationUbiquitin–proteasome pathway and cellular responses to oxidative stress
Shang, F., & Taylor, A. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.03.031 · Cited by 433
Lipofuscin: Formation, Distribution, and Metabolic Consequences
JUNG, T., BADER, N., & GRUNE, T. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1404.008 · Cited by 415
Self-citationJung, T., Catalgol, B., & Grune, T. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.001 · Cited by 389
Self-citationOxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis
Dasuri, K., Zhang, L., & Keller, J. N. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.09.016 · Cited by 371
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 359
Oxidative stress in Alzheimer's disease
Chauhan, V., & Chauhan, A. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.004 · Cited by 342
4-Hydroxynonenal and neurodegenerative diseases
Zarkovic, K. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00024-4 · Cited by 315
Sultana, R., Perluigi, M., & Butterfield, D. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2021 · Cited by 262
Protein damage, repair and proteolysis
Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila, K., Catalgol, B., Friguet, B., Grune, T., & Gonos, E. S. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.09.001 · Cited by 256
Self-citationDi Domenico, F., Tramutola, A., & Butterfield, D. A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.490 · Cited by 253
Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 248
Keller, J. (2002) · Ageing Research Reviews · doi:10.1016/s1568-1637(01)00006-x · Cited by 247
Protein oxidation in aging and the removal of oxidized proteins
Höhn, A., König, J., & Grune, T. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.01.004 · Cited by 238
Self-citationProtein turnover by the proteasome in aging and disease
Shringarpure, R., & Davies, K. J. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00824-9 · Cited by 237
Self-citationProteomics Analysis of the Alzheimer's Disease Hippocampal Proteome
Sultana, R., Boyd-Kimball, D., Cai, J., Pierce, W. M., Klein, J. B., Merchant, M., & Butterfield, D. A. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11203 · Cited by 230
4-Hydroxynonenal (HNE) modified proteins in metabolic diseases
Castro, J. P., Jung, T., Grune, T., & Siems, W. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.497 · Cited by 225
Self-citationProtein oxidation and 20S proteasome-dependent proteolysis in mammalian cells
Shringarpure, R., Grune, T., & Davies, K. J. A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000787 · Cited by 222
Self-citationAntioxidants and HNE in redox homeostasis
Łuczaj, W., Gęgotek, A., & Skrzydlewska, E. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.033 · Cited by 197
The proteasomal system and HNE-modified proteins
Grune, T., & Davies, K. J. A. (2003) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(03)00014-1 · Cited by 197
Self-citationAge-Related Changes in Protein Oxidation and Proteolysis in Mammalian Cells
Grune, T., Shringarpure, R., Sitte, N., & Davies, K. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.11.b459 · Cited by 193
Self-citationRegulation of proteasome-mediated protein degradation during oxidative stress and aging
Breusing, N., & Grune, T. (2008) · bchm · doi:10.1515/bc.2008.029 · Cited by 189
Self-citationHaces, M. L., Hernández-Fonseca, K., Medina-Campos, O. N., Montiel, T., Pedraza-Chaverri, J., & Massieu, L. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.029 · Cited by 187
Role of the ubiquitin proteasome system in Alzheimer's disease
Upadhya, S. C., & Hegde, A. N. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s12 · Cited by 186
Cheng, H., Saffari, A., Sioutas, C., Forman, H. J., Morgan, T. E., & Finch, C. E. (2016) · Environmental Health Perspectives · doi:10.1289/ehp134 · Cited by 167
Amyloid peptide attenuates the proteasome activity in neuronal cells
Oh, S., Hong, H. S., Hwang, E., Sim, H. J., Lee, W., Shin, S. J., & Mook-Jung, I. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.07.006 · Cited by 166
Higdon, A. N., Benavides, G. A., Chacko, B. K., Ouyang, X., Johnson, M. S., Landar, A., Zhang, J., & Darley-Usmar, V. M. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00584.2011 · Cited by 161
Oxidative Stress and Cell Membranes in the Pathogenesis of Alzheimer's Disease
Axelsen, P. H., Komatsu, H., & Murray, I. V. J. (2011) · Physiology · doi:10.1152/physiol.00024.2010 · Cited by 158
Fabiani, C., & Antollini, S. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00309 · Cited by 154
Protein quality control in Alzheimer's disease by the ubiquitin proteasome system
de Vrij, F. M. S., Fischer, D. F., VANLEEUWEN, F., & Hol, E. M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.10.001 · Cited by 171
Impaired proteostasis during skeletal muscle aging
Fernando, R., Drescher, C., Nowotny, K., Grune, T., & Castro, J. P. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.037 · Cited by 134
Self-citationJung, T., Höhn, A., & Grune, T. (2014) · Redox Biology · doi:10.1016/j.redox.2013.12.029 · Cited by 130
Self-citationPathophysiological importance of aggregated damaged proteins
Höhn, A., Jung, T., & Grune, T. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.02.028 · Cited by 137
Self-citationButterfield, D. A., & Sultana, R. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12107 · Cited by 126
Mullally, J. E., Moos, P. J., Edes, K., & Fitzpatrick, F. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102198200 · Cited by 118
Proteasomes and proteasome inhibition in the central nervous system
Ding, Q., & Keller, J. N. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00635-9 · Cited by 127
Lipofuscin inhibits the proteasome by binding to surface motifs
Höhn, A., Jung, T., Grimm, S., Catalgol, B., Weber, D., & Grune, T. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.011 · Cited by 113
Self-citationAlzheimer’ s disease, oxidative stress and gammahydroxybutyrate
Mamelak, M. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.008 · Cited by 118
Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis
Simpson, E. P., Yen, A. A., & Appel, S. H. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200311000-00008 · Cited by 115
Membrane-mediated Amyloidogenesis and the Promotion of Oxidative Lipid Damage by Amyloid β Proteins
Murray, I. V. J., Liu, L., Komatsu, H., Uryu, K., Xiao, G., Lawson, J. A., & Axelsen, P. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608589200 · Cited by 106
HALLIWELL, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04067.x · Cited by 103
Davies, S. S., Amarnath, V., Montine, K. S., Bernoud‐Hubac, N., Boutaud, O. G., Montine, T. J., & Roberts, L. J. (2002) · The FASEB Journal · doi:10.1096/fj.01-0696fje · Cited by 108
Sustained oxidative stress inhibits NF-κB activation partially via inactivating the proteasome
Wu, M., Bian, Q., Liu, Y., Fernandes, A. F., Taylor, A., Pereira, P., & Shang, F. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.021 · Cited by 96
Role of ubiquitin–proteasome-mediated proteolysis in nervous system disease
Hegde, A. N., & Upadhya, S. C. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.006 · Cited by 96
Extracellular vesicles in cancer´s communication: messages we can read and how to answer
Semerádtová, A., Liegertová, M., Herma, R., Čapková, M., Brignole, C., & Zotto, G. D. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02282-1 · Cited by 101
The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9063-4 · Cited by 98
Protein oxidation and proteolysis
Bader, N., & Grune, T. (2006) · bchm · doi:10.1515/bc.2006.169 · Cited by 89
Self-citationDavidson, K., & Pickering, A. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1124907 · Cited by 96
Contribution of the HNE-immunohistochemistry to modern pathological concepts of major human diseases
Žarković, K., Jakovčević, A., & Žarković, N. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.009 · Cited by 96
Oxidized proteins: Intracellular distribution and recognition by the proteasome
Jung, T., Bader, N., & Grune, T. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.030 · Cited by 98
Self-citationPromotion of Amyloid β Protein Misfolding and Fibrillogenesis by a Lipid Oxidation Product
Liu, L., Komatsu, H., Murray, I. V. J., & Axelsen, P. H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.01.057 · Cited by 91
Davies, K. J. A., & Shringarpure, R. (2006) · Neurology · doi:10.1212/01.wnl.0000192308.43151.63 · Cited by 80
Self-citationRetractedProtein oxidation and degradation during aging: Role in skin aging and neurodegeneration
Widmer, R., Ziaja, I., & Grune, T. (2006) · Free Radical Research · doi:10.1080/10715760600911154 · Cited by 76
Self-citationZhang, S., Eitan, E., Wu, T.-Y., & Mattson, M. P. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.09.016 · Cited by 73
Heat Shock Protein A2 (HSPA2): Regulatory Roles in Germ Cell Development and Sperm Function
Nixon, B., Bromfield, E. G., Cui, J., & Iuliis, G. N. D. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-51409-3_4 · Cited by 74
Oxidative Modification of Proteins: From Damage to Catalysis, Signaling, and Beyond
Demasi, M., Augusto, O., Bechara, E. J. H., Bicev, R. N., Cerqueira, F. M., da Cunha, F. M., Denicola, A., Gomes, F., Miyamoto, S., Netto, L. E. S., et al. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8176 · Cited by 74
Chocrón, E. S., Munkácsy, E., Kim, H. S., Karpowicz, P., Jiang, N., Skike, C. E. V., DeRosa, N., Banh, A. Q., Palavicini, J. P., Wityk, P., et al. (2022) · Science Advances · doi:10.1126/sciadv.abk2252 · Cited by 70
The Proteasome: A Target of Oxidative Damage in Cultured Human Retina Pigment Epithelial Cells
Zhang, X., Zhou, J., Fernandes, A. F., Sparrow, J. R., Pereira, P., Taylor, A., & Shang, F. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1559 · Cited by 68
Protein Lipoxidation: Basic Concepts and Emerging Roles
Viedma-Poyatos, Á., González-Jiménez, P., Langlois, O., Spickett, C. M., & Pérez‐Sala, D. (2021) · Antioxidants · doi:10.3390/antiox10020295 · Cited by 64
Proteolytic Response to Oxidative Stress in Mammalian Cells
Mehlhase, J., & Grune, T. (2002) · Biological Chemistry · doi:10.1515/bc.2002.057 · Cited by 69
Self-citationElkon, H., Melamed, E., & Offen, D. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:24:3:387 · Cited by 65
Shang, F., & Taylor, A. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.04.001 · Cited by 65
Cross-talk between redox signalling and protein aggregation
van Dam, L., & Dansen, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190054 · Cited by 47
Peroxynitrite-induced oxidation and its effects on isolated proteasomal systems
Amici, M., Lupidi, G., Angeletti, M., Fioretti, E., & Eleuteri, A. M. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01369-2 · Cited by 58
Bromfield, E. G., Aitken, R. J., McLaughlin, E. A., & Nixon, B. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw074 · Cited by 52
An overview of the role of lipid peroxidation-derived 4-hydroxynonenal in osteoarthritis
Abusarah, J., Bentz, M., Benabdoune, H., Rondon, P. E., Shi, Q., Fernandes, J., Fahmi, H., & Benderdour, M. (2017) · Inflammation Research · doi:10.1007/s00011-017-1044-4 · Cited by 53
Immunomodulatory effects of 4-hydroxynonenal
Ioannidis, M., Tjepkema, J., Uitbeijerse, M. R. P., & van den Bogaart, G. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103719 · Cited by 50
Tau is not normally degraded by the proteasome
Feuillette, S., Blard, O., Lecourtois, M., Frébourg, T., Campion, D., & Dumanchin, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20414 · Cited by 48
Mihalas, B. P., Bromfield, E. G., Sutherland, J. M., Iuliis, G. N. D., McLaughlin, E. A., Aitken, R. J., & Nixon, B. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005751 · Cited by 49
Oxidized protein aggregates: Formation and biological effects
Grune, T. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.02.014 · Cited by 46
Self-citationNitrotyrosine and protein carbonyls are equally distributed in HT22 cells after nitrosative stress
Jung, T., Engels, M., Klotz, L., Kröncke, K., & Grune, T. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.029 · Cited by 44
Self-citationProtein Carbonylation in Neurodegenerative and Demyelinating CNS Diseases
Bizzozero, O. A. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_23 · Cited by 49
Halliwell, B. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.2007 · Cited by 41
Ferritin oxidation and proteasomal degradation: Protection by antioxidants
Voss, P., Horakova, L., Jakstadt, M., Kiekebusch, D., & Grune, T. (2006) · Free Radical Research · doi:10.1080/10715760500419357 · Cited by 42
Self-citationAging and SKN-1-dependent Loss of 20S Proteasome Adaptation to Oxidative Stress in C. elegans
Raynes, R., Juarez, C., Pomatto, L. C. D., Sieburth, D., & Davies, K. J. A. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw093 · Cited by 44
Self-citationSha, W., Martins, A. M., Laubenbacher, R., Mendes, P., & Shulaev, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074939 · Cited by 42
Exploring Erythrocytes as Blood Biomarkers for Alzheimer’s Disease
Stevenson, A. J., Lopez, D., Khoo, P. L. Z., Kalaria, R. N., & Mukaetova-Ladinska, E. B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170363 · Cited by 40
Bromfield, E. G., Mihalas, B. P., Dun, M. D., Aitken, R. J., McLaughlin, E. A., Walters, J. L. H., & Nixon, B. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox005 · Cited by 36
Actin carbonylation: From cell dysfunction to organism disorder
Castro, J. P., Jung, T., Grune, T., & Almeida, H. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.05.006 · Cited by 37
Self-citationGeng, X. H., Yang, B., Li, R., Teng, T., LaDu, M. J., Sun, G. Y., Greenlief, C. M., & Lee, J. C. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01805-4 · Cited by 33
Proteasome activity in human lens nuclei and correlation with age, gender and severity of cataract
Zetterberg, M., Petersen, A. H., Sjöstrand, J., & Karlsson, J. (2003) · Current Eye Research · doi:10.1076/ceyr.27.2.45.15457 · Cited by 33
Oxidized SOD1 alters proteasome activities in vitro and in the cortex of SOD1 overexpressing mice
LePecheur, M., Bourdon, E., Paly, E., Farout, L., Friguet, B., & London, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.048 · Cited by 32
Safwat, M. H., El‐Sawalhi, M. M., Mausouf, M. N., & Shaheen, A. A. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914050095 · Cited by 32
Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration
Butterfield, D. A., & Boyd-Kimball, D. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)61007-5 · Cited by 31
Role of the Ubiquitin–Proteasome in Protein Quality Control and Signaling
Shang, F., & Taylor, A. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-397863-9.00010-9 · Cited by 29
The nuclear proteasome and the degradation of oxidatively damaged proteins
Voss, P., & Grune, T. (2006) · Amino Acids · doi:10.1007/s00726-006-0428-5 · Cited by 32
Self-citationImpact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease
Seike, T., Chen, C., & Mochly‐Rosen, D. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1223977 · Cited by 28
Degradation of oxidized extracellular proteins by microglia
Stolzing, A., Wengner, A. M., & Grune, T. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00003-6 · Cited by 29
Self-citationKnopp, R. C., Lee, S., Hollas, M. A. R., Nepomuceno, E., González, D., Tam, K. A., Aamir, D., Wang, Y., Pierce, E. N., BenAissa, M., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101486 · Cited by 29
Magni, F., Galbusera, C., Tremolada, L., Ferrarese, C., & Kienle, M. G. (2002) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.743 · Cited by 29
Latina, V., Caioli, S., Zona, C., Ciotti, M. T., Borreca, A., Calissano, P., & Amadoro, G. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00487 · Cited by 26
Metadata
- Authors
- Shringarpure, R., Grune, T., Sitte, N., & Davies*, K. J. A.
- Affiliations
- University of Southern California (US)
- Humboldt-Universität zu Berlin (DE)
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2000-10
- Volume
- 57
- Issue
- 12
- Pages
- 1802-1809
- ISSN
- 1420-682X (ISSN-L)
- PMC
- PMC11149552
- OpenAlex
- W2097355576
- Cited by
- 140
- References
- 35
- Citations by year
- 2025: 2 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 3 · 2018: 4 · 2017: 6 · 2016: 7 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 9
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Environmental Health Sciences (ES03598)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- amyloid-beta, 4-hydroxynonenal, proteasome inhibition, Alzheimer's disease, oxidative stress, hydrogen peroxide, lipid peroxidation, 20S proteasome, protein oxidation, Aβ40, fluorogenic peptide substrates
- MeSH terms
- Aldehydes, Alzheimer Disease, Cysteine Endopeptidases, Erythrocytes, Hemoglobins, Humans, Hydrogen Peroxide, Multienzyme Complexes, Oxidation-Reduction, Oxyhemoglobins, Peptide Fragments, Protease Inhibitors, Lipid Peroxidation, Amyloid beta-Peptides, Proteasome Endopeptidase Complex, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.